Issued patent and new reagent launch position MICRO-TAG® as a real-time cellular platform for unlocking challenging drug targets. MICRO-TAG enables discovery teams to unlock challenging drug targets ...
This article and associated images are based on a poster originally authored by Paulina Chorobik, Maciej B. Olszewski, John Vincent and Kirsty Winn and presented at ELRIG Drug Discovery 2025 in ...
Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate ...
QurAlis intends to advance QRL-101 into Phase 2 proof-of-concept clinical trials as a potentially best-in-class treatment for both DEE and ALS QurAlis Corporation (“QurAlis”), a clinical-stage ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results